CA999868A - Biologically active compounds - Google Patents

Biologically active compounds

Info

Publication number
CA999868A
CA999868A CA167,818A CA167818A CA999868A CA 999868 A CA999868 A CA 999868A CA 167818 A CA167818 A CA 167818A CA 999868 A CA999868 A CA 999868A
Authority
CA
Canada
Prior art keywords
biologically active
active compounds
compounds
biologically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA167,818A
Other languages
English (en)
Other versions
CA167818S (en
Inventor
Kurt Engel
David E. Thorne
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of CA999868A publication Critical patent/CA999868A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA167,818A 1972-04-04 1973-04-03 Biologically active compounds Expired CA999868A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1528072A GB1437781A (en) 1972-04-04 1972-04-04 Pyridine derivatives having hypoglycaemic activity

Publications (1)

Publication Number Publication Date
CA999868A true CA999868A (en) 1976-11-16

Family

ID=10056262

Family Applications (1)

Application Number Title Priority Date Filing Date
CA167,818A Expired CA999868A (en) 1972-04-04 1973-04-03 Biologically active compounds

Country Status (20)

Country Link
JP (1) JPS49100091A (pl)
AR (1) AR208269A1 (pl)
AT (1) AT339301B (pl)
BE (1) BE797715A (pl)
BG (1) BG20352A3 (pl)
CA (1) CA999868A (pl)
CH (1) CH576961A5 (pl)
CS (1) CS183689B2 (pl)
DD (1) DD106834A5 (pl)
DE (1) DE2316881A1 (pl)
ES (1) ES413279A1 (pl)
FR (1) FR2182933B1 (pl)
GB (1) GB1437781A (pl)
HU (1) HU165731B (pl)
IE (1) IE37412B1 (pl)
IL (1) IL41825A (pl)
NL (1) NL7304610A (pl)
PL (1) PL96043B1 (pl)
RO (2) RO63069A (pl)
ZA (1) ZA731853B (pl)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4409227A (en) 1979-08-09 1983-10-11 The Dow Chemical Co. 4-(((Heterocyclo)thio)methyl)benzoic acids, esters and amides and their pharmaceutical use
EP0530864B1 (en) * 1991-07-03 1995-04-19 Unilever N.V. Improved chocolate compositions
ATE126673T1 (de) * 1991-07-03 1995-09-15 Unilever Nv Pralinenfüllung enthaltend ein zusatzmittel gegen fettbelag.
US5453433A (en) * 1994-05-13 1995-09-26 Sterling Winthrop Inc. Thiadiazoles and antipicornaviral compositions
US6043247A (en) * 1996-04-19 2000-03-28 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
AU2381497A (en) * 1996-04-19 1997-11-12 Novo Nordisk A/S Modulators of molecules with phosphotyrosine recognition units
US6329372B1 (en) 1998-01-27 2001-12-11 Celltech Therapeutics Limited Phenylalanine derivatives
ES2226413T3 (es) 1998-02-26 2005-03-16 Celltech Therapeutics Limited Derivados de fenilalanina como inhibidores de alfa-4 integrinas.
GB9805655D0 (en) 1998-03-16 1998-05-13 Celltech Therapeutics Ltd Chemical compounds
US6521626B1 (en) 1998-03-24 2003-02-18 Celltech R&D Limited Thiocarboxamide derivatives
GB9811159D0 (en) 1998-05-22 1998-07-22 Celltech Therapeutics Ltd Chemical compounds
GB9811969D0 (en) 1998-06-03 1998-07-29 Celltech Therapeutics Ltd Chemical compounds
GB9812088D0 (en) 1998-06-05 1998-08-05 Celltech Therapeutics Ltd Chemical compounds
GB9814414D0 (en) * 1998-07-03 1998-09-02 Celltech Therapeutics Ltd Chemical compounds
GB9821061D0 (en) 1998-09-28 1998-11-18 Celltech Therapeutics Ltd Chemical compounds
GB9821222D0 (en) 1998-09-30 1998-11-25 Celltech Therapeutics Ltd Chemical compounds
GB9825652D0 (en) 1998-11-23 1999-01-13 Celltech Therapeutics Ltd Chemical compounds
GB9826174D0 (en) 1998-11-30 1999-01-20 Celltech Therapeutics Ltd Chemical compounds
US6518283B1 (en) 1999-05-28 2003-02-11 Celltech R&D Limited Squaric acid derivatives
US6534513B1 (en) 1999-09-29 2003-03-18 Celltech R&D Limited Phenylalkanoic acid derivatives
US6455539B2 (en) 1999-12-23 2002-09-24 Celltech R&D Limited Squaric acid derivates
WO2001079173A2 (en) 2000-04-17 2001-10-25 Celltech R & D Limited Enamine derivatives as cell adhesion molecules
US6403608B1 (en) 2000-05-30 2002-06-11 Celltech R&D, Ltd. 3-Substituted isoquinolin-1-yl derivatives
US6545013B2 (en) 2000-05-30 2003-04-08 Celltech R&D Limited 2,7-naphthyridine derivatives
EP1301488A1 (en) 2000-07-07 2003-04-16 Celltech R&D Limited Squaric acid derivatives containing a bicyclic heteroaromatic ring as integrin antagonists
AU2001275724A1 (en) 2000-08-02 2002-02-13 Celltech R&D Limited 3-substituted isoquinolin-1-yl derivatives
US7101910B2 (en) * 2001-06-12 2006-09-05 Wellstat Therapeutics Corporation Compounds for the treatment of metabolic disorders
GB0405033D0 (en) * 2004-03-05 2004-04-07 Karobio Ab Novel pharmaceutical compositions
TWI490214B (zh) * 2008-05-30 2015-07-01 艾德克 上野股份有限公司 苯或噻吩衍生物及該等作為vap-1抑制劑之用途
EP3019034B1 (en) 2013-07-01 2018-10-31 Givaudan SA Organic compounds
CN107529803B (zh) * 2015-04-15 2021-03-30 长谷川香料株式会社 以吡啶衍生物或其盐作为有效成分的香味调制剂
US11096909B2 (en) 2016-04-06 2021-08-24 University Of Oulu Compounds for use in the treatment of cancer

Also Published As

Publication number Publication date
AT339301B (de) 1977-10-10
ATA286773A (de) 1977-02-15
GB1437781A (en) 1976-06-03
DE2316881A1 (de) 1973-10-11
NL7304610A (pl) 1973-10-08
BE797715A (fr) 1973-10-03
IE37412L (en) 1973-10-04
FR2182933B1 (pl) 1976-05-14
FR2182933A1 (pl) 1973-12-14
DD106834A5 (pl) 1974-07-05
CH576961A5 (pl) 1976-06-30
BG20352A3 (bg) 1975-11-05
ES413279A1 (es) 1976-01-01
PL96043B1 (pl) 1977-11-30
AR208269A1 (es) 1976-12-20
RO63069A (fr) 1978-08-15
HU165731B (pl) 1974-10-28
ZA731853B (en) 1974-01-30
CS183689B2 (en) 1978-07-31
IE37412B1 (en) 1977-07-20
RO62274A (fr) 1977-12-15
JPS49100091A (pl) 1974-09-20
IL41825A0 (en) 1973-05-31
IL41825A (en) 1977-03-31

Similar Documents

Publication Publication Date Title
CA999868A (en) Biologically active compounds
AU472456B2 (en) Pharmacologically active compounds
CA1010781A (en) Insecticidal composition
AU473158B2 (en) Pharmacologically active compounds
AU473752B2 (en) Pharmacologically active compounds
CA1034952A (en) Piperazino-anilido compounds
CA1005447A (en) Imino-isoindoline compounds
AU469525B2 (en) Biologically active di-aryl compounds
AU3483871A (en) Biologically active compound
CA914065A (en) Biologically active emulsions
CA1010884A (en) Trimethylfluoran compounds
AU2786271A (en) Biologically active material
CA1005443A (en) Thienodiazepine compounds
CA1010037A (en) Benzimidazolinone compounds
ZA738505B (en) Biologically active compounds
CA966830A (en) Biologically active substance
AU2858971A (en) Biologically active substance
AU478874B2 (en) Biologically active compounds
AU481110B2 (en) Biologically active compounds and compositions
AU6513474A (en) Biologically active compounds
CA958335A (en) Biologically active substance
AU452713B2 (en) Biologically active substance
AU482278B2 (en) Insecticide
AU482511B2 (en) Insecticide
AU5873273A (en) Biologically active compounds and compositions